{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:03:41Z","timestamp":1793703821728,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006380","name":"Rehabilitation Research and Development Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jns.2021.120124","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T21:31:57Z","timestamp":1640899917000},"page":"120124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults"],"prefix":"10.1016","volume":"434","author":[{"given":"Hesham","family":"Abboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farren","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Buerki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkasaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe Fernandez","family":"BacaVaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Fotedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Griggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeet","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Winegardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasef","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2021.120124_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120124_bb0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.120124_bb0015","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120124_bb0020","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"323","key":"10.1016\/j.jns.2021.120124_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.07.009","article-title":"Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction","author":"Dubey","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jns.2021.120124_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jns.2021.120124_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS consensus conference","volume":"25","author":"Chang","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2021.120124_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/cap.2014.0048","article-title":"Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder","volume":"25","author":"Cox","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol"},{"issue":"11","key":"10.1016\/j.jns.2021.120124_bb0045","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00415-017-8627-4","article-title":"Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results","volume":"264","author":"Abboud","year":"2017","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120124_bb0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.25421","article-title":"Development of the clinical assessment scale in autoimmune encephalitis","volume":"85","author":"Lim","year":"2019","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120124_bb0055","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for Paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.jns.2021.120124_bb0060","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-020-10341-4","article-title":"NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab","volume":"268","author":"Martin","year":"2021","journal-title":"J. Neurol."},{"issue":"19","key":"10.1016\/j.jns.2021.120124_bb0065","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2021.120124_bb0070","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51137","article-title":"Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABAB R encephalitis","volume":"7","author":"Shen","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120124_bb0075","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2021.120124_bb0080","article-title":"Characteristics and prognosis of autoimmune encephalitis in the east of China: a multi-center study","author":"Qiao","year":"2021","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2021.120124_bb0085","article-title":"A validated nomogram that predicts prognosis of autoimmune encephalitis: a multicenter study in China","author":"Sun","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.120124_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: a systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jns.2021.120124_bb0095","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2019.01286","article-title":"Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2021.120124_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107088","article-title":"Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis","volume":"108","author":"Blum","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"48","key":"10.1016\/j.jns.2021.120124_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013223","article-title":"The role of cognitive rehabilitation in limbic encephalitis: a case report","volume":"97","author":"Corallo","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.jns.2021.120124_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001033","article-title":"Autoimmune neurology: the need for comprehensive care","volume":"8","author":"Abbatemarco","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21028318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21028318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:16Z","timestamp":1758384016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21028318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":22,"alternative-id":["S0022510X21028318"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120124","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120124"}}